Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;23(6):919-932.
doi: 10.1002/ejhf.2036. Epub 2020 Dec 4.

High soluble transferrin receptor in patients with heart failure: a measure of iron deficiency and a strong predictor of mortality

Radoslaw Sierpinski  1   2 , Krystian Josiak  3   4 , Tomasz Suchocki  5 , Katarzyna Wojtas-Polc  3   6 , Grzegorz Mazur  7 , Aleksandra Butrym  7 , Piotr Rozentryt  8 , Peter van der Meer  9 , Josep Comin-Colet  10   11 , Stephan von Haehling  12 , Wojciech Kosmala  4   13 , Monika Przewlocka-Kosmala  4   13 , Waldemar Banasiak  6 , Jolanta Nowak  8 , Adriaan A Voors  9 , Stefan D Anker  12 , John G F Cleland  14 , Piotr Ponikowski  3   4 , Ewa A Jankowska  3   4
Affiliations
Free article

High soluble transferrin receptor in patients with heart failure: a measure of iron deficiency and a strong predictor of mortality

Radoslaw Sierpinski et al. Eur J Heart Fail. 2021 Jun.
Free article

Erratum in

Abstract

Aims: Iron deficiency (ID) is frequent in heart failure (HF), linked with exercise intolerance and poor prognosis. Intravenous iron repletion improves clinical status in HF patients with left ventricular ejection fraction (LVEF) ≤45%. However, uncertainty exists about the accuracy of serum biomarkers in diagnosing ID. The aims of this study were (i) to identify the iron biomarker with the greatest accuracy for the diagnosis of ID in bone marrow in patients with ischaemic HF, and (ii) to establish the prevalence of ID using this biomarker and its prognostic value in HF patients.

Methods and results: Bone marrow was stained for iron in 30 patients with ischaemic HF with LVEF ≤45% and 10 healthy controls, and ID was diagnosed for 0-1 grades (Gale scale). A total of 791 patients with HF with LVEF ≤45% were prospectively followed up for 3 years. Serum ferritin, transferrin saturation, soluble transferrin receptor (sTfR) were assessed as iron biomarkers. Most patients with HF (n = 25, 83%) had ID in bone marrow, but none of the controls (P < 0.001). Serum sTfR had the best accuracy in predicting ID in bone marrow (area under the curve 0.920, 95% confidence interval 0.761-0.987, for cut-off 1.25 mg/L sensitivity 84%, specificity 100%). Serum sTfR was ≥1.25 mg/L in 47% of HF patients, in 56% and 46% of anaemics and non-anaemics, respectively (P < 0.05). The reclassification methods revealed that serum sTfR significantly added the prognostic value to the baseline prognostic model, and to the greater extent than plasma N-terminal pro B-type natriuretic peptide. Based on internal derivation and validation procedures, serum sTfR ≥1.41 mg/L was the optimal threshold for predicting 3-year mortality, independent of other established variables.

Conclusions: High serum sTfR accurately reflects depleted iron stores in bone marrow in patients with HF, and identifies those with a high 3-year mortality.

Keywords: Bone marrow; Heart failure; Iron deficiency; Mortality; Prognosis; Soluble transferrin receptor.

PubMed Disclaimer

References

    1. Zimmermann MB, Hurrell RF. Nutritional iron deficiency. Lancet 2007;370:511-520.
    1. Tkaczyszyn M, Drozd M, Ponikowski P, Jankowska EA. Iron deficiency in heart failure: a 2020 update. Kardiol Pol 2019;77:1134-1139.
    1. Jankowska EA, Rozentryt P, Witkowska A, Nowak J, Hartmann O, Ponikowska B, Borodulin-Nadzieja L, Banasiak W, Polonski L, Filippatos G, McMurray JJ, Anker SD, Ponikowski P. Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J 2010;31:1872-1880.
    1. Jankowska EA, Malyszko J, Ardehali H, Koc-Zorawska E, Banasiak W, von Haehling S, Macdougall IC, Weiss G, McMurray JJ, Anker SD, Gheorghiade M, Ponikowski P. Iron status in patients with chronic heart failure. Eur Heart J 2013;34:827-834.
    1. Okonko DO, Mandal AK, Missouris CG, Poole-Wilson PA. Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival. J Am Coll Cardiol 2011;58:1241-1251.

Publication types